产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 |
CAS No. |
1448754-43-5 |
|---|---|
中文名称 |
4-(嘧啶-2-基甲基)-7-(4-(三氟甲氧基)苯基)-3,4-二氢苯并[f][1,4]氧氮杂卓-5(2H)-酮 盐酸盐 |
英文名称 |
4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one hydrochloride |
别名 |
BS-15137 | 1622226-81-6 | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one;hydrochloride | 4R1JP3Q4HI | GS 6615 hydrochlorideGS 6615 hydrochloride | 1448754-43-5 | UNII-4R1JP3Q4HI | Eleclazine hydrochloride | 1,4- |
标准英文名 |
4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one hydrochloride |
分子式 |
C21H17ClF3N3O3 |
分子量 |
451.83 |
精确分子量 |
451.09 |
SMILES |
O=C1N(CC2=NC=CC=N2)CCOC3=CC=C(C4=CC=C(OC(F)(F)F)C=C4)C=C13.[H]Cl |
标准SMILES |
Cl.O=C1C2=CC(=CC=C2OCCN1CC1N=CC=CN=1)C1C=CC(=CC=1)OC(F)(F)F |
性状 |
White to light-yellow solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ZRYHNOXHGYUHFF-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Keep in dark place,Inert atmosphere,Room temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|